Douglas P. Golwas - 15 Jun 2026 Form 4 Insider Report for Medline Inc. (MDLN)

Reporting relationship: Chief Commercial Officer, 10%+ Owner
Issuer ticker: MDLN
Reported as of: 15 Jun 2026
Net transaction value: -$3,677,115
SEC form: 4
Accepted by SEC: 17 Jun 2026, 16:44:05 UTC
Prior SEC filing: 17 Dec 2025
Source filing: View source filing
Reporting owner signature: /s/ Nicole Fritz, Attorney-in-Fact

Key filing fact

Douglas P. Golwas filed Form 4 for Medline Inc. (MDLN) on 17 Jun 2026.

Key facts

This page summarizes Douglas P. Golwas's Form 4 filing for Medline Inc. (MDLN).
6 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 17 Jun 2026, 16:44.

Change

Previous filing in this sequence was filed on 17 Dec 2025.
Current net transaction value: -$3,677,115.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002061504 Primary reporting owner

Golwas Douglas P

Relationship: Chief Commercial Officer, 10%+ Owner
Address: C/O MEDLINE INC., 3 LAKES DRIVE, NORTHFIELD
Signature: /s/ Nicole Fritz, Attorney-in-Fact
Signature date: 17 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MDLN transaction

Class A Common Stock

Tax liability

Transaction value
Shares: -1,889
Change %: -7.3%
Price: $36.61^*
Shares after: 23,899
Date: 15 Jun 2026
Ownership: Direct
Footnotes: F1

MDLN transaction

Class A Common Stock

Options Exercise

Transaction value
Shares: +100,000
Change %: +418%
Price
Shares after: 123,899
Date: 16 Jun 2026
Ownership: Direct
Footnotes: F2

MDLN transaction

Class A Common Stock

Sale

Transaction value: $2,267,956
Shares: -61,966
Change %: -50%
Price: $36.60
Shares after: 61,933
Date: 16 Jun 2026
Ownership: Direct
Footnotes: F3, F4

MDLN transaction

Class A Common Stock

Sale

Transaction value: $1,409,160
Shares: -38,034
Change %: -61%
Price: $37.05
Shares after: 23,899
Date: 16 Jun 2026
Ownership: Direct
Footnotes: F3, F5

MDLN transaction

Class B Common Stock

Disposed to Issuer

Transaction value
Shares: -100,000
Change %: -21%
Price
Shares after: 365,864
Date: 16 Jun 2026
Ownership: Direct
Footnotes: F6

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MDLN transaction Derivative

Common Units of Medline Holdings, LP

Options Exercise

Transaction value
Shares: -100,000
Change %: -21%
Price: $0.000000^*
Shares after: 365,864
Date: 16 Jun 2026
Ownership: See Footnote
Underlying class: Class A Common Stock
Underlying amount: 100,000
Exercise price
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 6 footnotes

Footnote F1

Reflects shares withheld to satisfy the Reporting Person's tax liability in connection with the vesting of restricted stock units.

Footnote F2

Pursuant to the terms of an exchange agreement, dated as of December 16, 2025, holders have the right to exchange their common units of Medline Holdings, LP ("Common Units") for shares of Medline Inc.'s (the "Issuer") Class A common stock ("Class A Common Stock") on a one-for-one basis, subject to customary conversion rate adjustments for stock splits, stock dividends and reclassifications. These exchange rights do not expire. Such Common Units were held indirectly through Medline Management Aggregator LLC.

Footnote F3

Reflects sales effected pursuant to a Rule 10b5-1 trading plan adopted on March 11, 2026.

Footnote F4

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.98 to $36.9785 per share, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F5

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.98 to $37.19 per share, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F6

Shares of the Issuer's Class B common stock ("Class B Common Stock") have no economic value and have one vote per share. One share of Class B Common Stock is issued for each Common Unit held. Upon the exchange of Common Units for shares of Class A Common Stock, an equivalent number of shares of Class B Common Stock were automatically cancelled.